Cargando…

Antidyslipidemic drugs in metabolic syndrome

Detalles Bibliográficos
Autor principal:	Patil, Anant D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2013
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872704/ https://www.ncbi.nlm.nih.gov/pubmed/24381903 http://dx.doi.org/10.4103/2230-8210.122652

Ejemplares similares

Antihypertensive, antidyslipidemic, and renoprotective effects of Bursera simaruba on metabolic syndrome
por: Alejandrina Guzmán Hernández, Elizabeth, et al.
Publicado: (2023)

Studies on the antihypertensive and antidyslipidemic activities of Viola odorata leaves extract
por: Siddiqi, Hasan S, et al.
Publicado: (2012)

Response to “Levofloxacin-containing versus Clarithromycin-containing Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial”
por: Patil, Anant D
Publicado: (2018)

Studies on antidyslipidemic effects of Morinda citrifolia (Noni) fruit, leaves and root extracts
por: Mandukhail, Saf-ur Rehman, et al.
Publicado: (2010)

Response to “A comparative study of alpha-1a blockers (tamsulosin) versus estrogens in the treatment of lower urinary tract symptoms in perimenopausal females”
por: Patil, Anant
Publicado: (2020)

Does orally dissolving formulation of clobazam provide clinical advantage over it's standard formulation
por: Patil, Anant Dhondopant
Publicado: (2016)

Chrysin Induces Antidiabetic, Antidyslipidemic and Anti-Inflammatory Effects in Athymic Nude Diabetic Mice
por: Ramírez-Espinosa, Juan José, et al.
Publicado: (2017)

Antihyperglycemic and antidyslipidemic activity of Musa paradisiaca‐based diet in alloxan‐induced diabetic rats
por: Ajiboye, Basiru O., et al.
Publicado: (2017)

In vivo hypoglycemic, antihyperglycemic and antidyslipidemic effects of the solvent fractions of Hagenia abyssinica leaves in mice
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Studies on two polyherbal formulations (ZPTO and ZTO) for comparison of their antidyslipidemic, antihypertensive and endothelial modulating activities
por: Aziz, Nauman, et al.
Publicado: (2013)

Antidiabetic and Antidyslipidemic Activities of the Aqueous Extract of Cochlospermum planchonii Leaves in Streptozotocin-Induced Diabetic Rats
por: Abraham, Bamisaye Fisayo, et al.
Publicado: (2017)

Antioxidant, antihyperglycemic, and antidyslipidemic effects of Brazilian-native fruit extracts in an animal model of insulin resistance
por: de Souza Cardoso, Juliane, et al.
Publicado: (2017)

Antidyslipidemic Potential of Water-Soluble Polysaccharides of Ganoderma applanatum in MACAPOS-2-Induced Obese Rats
por: Mfopa, Adamou, et al.
Publicado: (2021)

Evaluation of in vivo antidiabetic, antidyslipidemic, and in vitro antioxidant activities of hydromethanolic root extract of Datura stramonium L. (Solanaceae)
por: Belayneh, Yaschilal Muche, et al.
Publicado: (2019)

Antidiabetic Activity of Hydromethanolic Extract of Crude Dorstenia barnimiana Root: Validation of In Vitro and In Vivo Antidiabetic and Antidyslipidemic Activity
por: Sisay, Woretaw, et al.
Publicado: (2022)

Recurrent Encephalopathy with Metabolic Acidosis and Hypoglycemia: Do not Forget Fructose Metabolism
por: Hiremath, Prabhudev M., et al.
Publicado: (2022)

Is metabolic syndrome prevailing in Iraqi children?
por: Al-Mendalawi, Mahmood D.
Publicado: (2014)

Metabolic Syndrome in School Children
por: Battaloğlu İnanç, Betül
Publicado: (2013)

The metabolic syndrome, anthropometry and microalbumin
por: Wiwanitkit, Viroj
Publicado: (2011)

Anaesthetic considerations in metabolic syndrome X
por: Goel, Nitesh, et al.
Publicado: (2010)

Waist circumference cutoff and metabolic syndrome
por: Joob, Beuy, et al.
Publicado: (2012)

Problems in the Japanese criteria for metabolic syndrome
por: Oda, Eiji
Publicado: (2011)

Metabolic syndrome and associated risk factors
por: Bhadoria, Ajeet Singh
Publicado: (2015)

Leptin as an independent marker of metabolic syndrome
por: Joob, Beuy, et al.
Publicado: (2017)

Metabolic syndrome in childhood cancer survivors
por: Firoz, Amena, et al.
Publicado: (2022)

Drug-induced hemolytic uremic syndrome
por: Cavoli, G. Li, et al.
Publicado: (2011)

Antidyslipidemic Drug Prescriptions and Lipid Control Status After Unfavorable Annual Health Checkup Results: A Retrospective Cohort Study Using a Health Insurance Database
por: Nozawa, Kazutaka, et al.
Publicado: (2021)

Time to take stock of Indian regulatory guidelines regarding drug use in pregnancy and lactation
por: Arora, Aashima, et al.
Publicado: (2019)

The Etiology of Metabolic Disturbances in Schizophrenia: Drugs, Genes, and Environment
por: Reynolds, Gavin P
Publicado: (2021)

Resolution of acquired Brown syndrome with oral steroid therapy
por: Chhablani, Preeti Patil, et al.
Publicado: (2017)

A Very Rare Combination of Hantavirus Cardiopulmonary Syndrome and Hanta Hemorrhagic Fever with Renal Syndrome
por: Reddy, Sudha Prasanth, et al.
Publicado: (2023)

Prevalence of metabolic syndrome in adolescents: Reason to worry
por: Angurana, Suresh Kumar, et al.
Publicado: (2013)

Metabolic syndrome in end stage renal disease
por: Mortazavi, Mojgan, et al.
Publicado: (2014)

Advanced Mitochondrial DNA Assay for Metabolic Syndrome
por: Sohn, Joon Hyung
Publicado: (2016)

ECEIM consensus statement on equine metabolic syndrome
por: MacLeod, Clare
Publicado: (2019)

A Case of Drug-resistant Epilepsy Associated with Ring Chromosome 20
por: Balabhadra, Anvesh, et al.
Publicado: (2021)

Antidyslipidemic potential of a novel farnesoid X receptor antagonist in a hamster model of dyslipidemia: Comparative studies of other nonstatin agents
por: Shinozawa, Emiko, et al.
Publicado: (2018)

Antidyslipidemic, Anti-Inflammatory, and Antioxidant Activities of Aqueous Leaf Extract of Dioscoreophyllum cumminsii (Stapf) Diels in High-Fat Diet-Fed Rats
por: Ibitoye, O. B., et al.
Publicado: (2017)

Hypoglycemic, antidyslipidemic and antioxydant effects of Vitellaria paradoxa barks extract on high-fat diet and streptozotocin-induced type 2 diabetes rats
por: Miaffo, David, et al.
Publicado: (2020)

Higher Pentraxin-3 Level in Patients with Metabolic Syndrome
por: Balta, Sevket, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s3httmphn7g9cm881tdocq5eap